Trials / Sponsors / Chang-Ming Huang, Prof.

Chang-Ming Huang, Prof.

Academic / Other · 10 registered clinical trials.

Status	Trial	Phase	Started
Completed	Trajectory of Body Composition Identifies LAGC with Cachexia Following NACT Locally Advanced Gastric Cancer, Trajectory	—	2024-09-12
Completed	Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Gastric Cancer	—	2024-06-10
Completed	Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients Stomach Neoplasms, Gastrectomy, Machine Learning	—	2024-06-01
Completed	Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patien Lymph Node-negative, Gastric Cancer	—	2024-05-01
Completed	ML Decision Model for G-NEC Adjuvant Therapy Gastric Neuroendocrine Carcinoma (G-NEC), Postoperative Adjuvant Therapy for G-NEC, Survival Outcomes	—	2024-01-01
Completed	Model for Prognosis of Elderly Gastric Cancer Patients Stomach Neoplasms, Aged	—	2024-01-01
Completed	Prediction Model for Advanced Gastric Cancer in Elderly Stomach Neoplasms, Aged	—	2024-01-01
Completed	Integrating Multi-Omics Data for Enhanced Prognosis Prediction in Gastric Cancer Post-Neoadjuvant Therapy Gastric Cancer (GC)	—	2019-01-01
Completed	Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Immunotherapy Gastrict Cancer, Inflammation Biomarkers, Gastric Cancers	—	2018-01-01
Unknown	Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer Apatinib Combined, SOX, Neoadjuvant Therapy	Phase 2	2017-09-01